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CHAPTER I. INTRODUCTION
Previous Research (Central Stimulation)
Grossman (I960) has found anatomically overlapping neural systems 
in a circumscribed region of the lateral hypothalamus which participate 
in the regulation of food and water intake can be separated on a neuro- 
chemical basis. The hypothalamic feeding system, which corresponds to 
the "feeding area" of Anand and Brobeck (1951) and to that area con­
cerned with the activation of specific feeding mechanisms discussed 
by Morgane (1961), was found to be selectively sensitive to adrenergic 
stimulation. The system regulating water intake was found to be under 
cholinergic mediation. The direct application of carbachol (a cholino­
mimetic which is highly resistant to the action of cholinesterase) to 
this region resulted in increased water intake. This effect could be 
abolished by pretreating the subject with atropine sulfate, an anti­
cholinergic agent, prior to central stimulation (Grossman, 1962).
While the structures involved in water intake have been extended 
by research involving the central application of pharmacological 
agents, the specificity of the relationship between cholinergic activ­
ity and drinking behavior has been maintained. Grossman (1964a) found 
that stimulation of the ventral amygdala with doses of less than 0.5/*g 
of carbachol led to an increase in the response rate of rats trained 
on a VI 4 minute schedule for water reinforcement. Atropine was found 
to decrease the response rate for water.
The administration of carbachol to the medial septal area leads 
to the initiation of drinking behavior in sated rats, and to an
increase in water consumption by water-deprived rats (Grossman, 1964b). 
The application of atropine to the same area resulted in decreased 
water intake by deprived rats— a result that has not been confirmed 
by later studies. Levitt and Fisher (1966) found that subjects who 
received atropine centrally as well as carbachol drank only 10$ as 
much as did those subjects receiving carbachol alone. However, the 
central application of atropine had no effect on thirst induced by *
23 hours of water deprivation, a result they later replicated (Levitt 
& Fisher, 196?). The issue is further complicated by the finding 
that while anticholinergic stimulation had no effect on deprivation- 
induced thirst when only water was present in the test cage, it did 
have a slight depressant effect when both food and water were present 
(Levitt, 1968).
Fisher and Coury (1962) have suggested that there is a •'medially 
oriented, generalized Papez circuit" regulating thirst-related 
behavior. They obtained drinking behavior following the injection 
of carbachol into the dorsomedial hippocampus (area of the dentate 
gyrus), septal regions, area of the diagonal band, the reuniens- 
mesial thalamic region, perifornical and preoptic regions, anterior 
thalamus (anterodorsal and anteroventral nuclei), lateral hypothalamus, 
mammillary-interpeduncular regions, and the cingulate cortex. These 
positive regions are all either a part of the original Papez circuit, 
which includes the hippocampus, fornix, mammillary regions of the 
hypothalamus, anterior nucleus of the thalamus, cingulate gyrus, and 
again the hippocampus, or are closely associated with it.
Levitt and Fisher (1966) found that the application of a cholin­
ergic antagonist to many of the limbic and diencephalic structures 
(cholinergic stimulation of which leads to thirst) prevented drinking 
in response to cholinergic stimulation of other parts of the system.
As stated above, however, the necessity for the functional integrity 
of the entire system was not apparent in the case of deprivation- 
induced thirst. This result may perhaps be due to peripheral feed­
back mechanisms (including throat and mouth receptors, osmoreceptors, 
etc.) that are active only during deprivation-induced thirst. Input 
from such receptors to central triggering mechanisms may serve to 
allow the system to operate even though one or more of the components 
are blocked.
The role of acetylcholine in drinking behavior can be further 
specified, Stein and Seifter (1962), finding a depression of cholin­
ergic drinking with atropine pretreatment of the same site that received 
cholinergic stimulation, concluded that the cholinergic thirst system 
is a muscarinic system, a conclusion confirmed by Levitt (1969). 
Stimulating several areas of the thirst system (including the lateral 
septal nucleus, the anterior thalamic nucleus, the dorsal fornix, and 
the anterior medial midbrain) prior to stimulation of the same or 
another of these areas with carbachol, Levitt found that only anti- 
muscarinic agents consistently blocked cholinergic thirst. Atropine 
sulfate, a muscarinic blocking agent, blocked cholinergic thirst 
(blockage defined as the consumption of 3.9 ml or less in a one-hour 
test period) in as much as 96$ of the tested -sites. Scopolamine
hydrobrord.de, another muscarinic blocking agent, produced up to 100$ 
blockage of cholinergic thirst. This result is consistent with find­
ings that atropine tends to be a somewhat less potent antimuscarinic 
agent in other physiological systems (Cullumbine, 196?). Among those 
agents which failed to produce consistent blockage of cholinergic 
thirst were dihydro-/3-erythroidine (an anticholinergic neuromuscular 
blocking agent) and hexamethonium (a ganglionic blocking agent). 
Application of strychnine, a central nervous system stimulant which 
has been found to be a cholinesterase inhibitor (Nachmansohn, 1938), 
resulted in a 52$ blockage of cholinergic thirst. Finally, those 
chemicals which effectively blocked cholinergically-induced thirst 
did so more consistently when placed at a site different from the 
carbachol site than when the two chemicals were placed at the same 
site. This result is consistent with the cholinergic thirst hypothesis. 
"When placed at a different site the test agent had only to block the 
naturally occurring acetylcholine, while if the agents were both
placed at the same site the test agent had to block the carbachol as
%
well as any naturally occurring acetylcholine.
In summary, the results of studies using central stimulation tech­
niques suggest the existence of an interconnected circuit which acts 
in the expression of thirst and thirst-related behavior. This circuit 
contains the major structures proposed by Papez (1937) to be involved 
in the expression of emotion, as well as several other closely inte­
grated structures. The data also strongly indicates that acetylcholine 
acts as the primary transmitter agent in this circuit, and further
that this cholinergic system is specifically muscarinic.
Previous Research (Peripheral Administration)
The peripheral application of atropine and scopolamine has been 
found to suppress eating as well as drinking behavior, Stein (1963) 
found that atropine (5 mg/kg) and scopolamine (.4- mg/kg) given i.p. 
to food or water deprived rats significantly suppressed both food and 
water intake. The effect on water intake would appear to be dose- 
related, since a dose magnitude of 2 ,5 mg/kg atropine failed to sig­
nificantly suppress drinking. However, doses of 1 mg/kg atropine did 
produce significant suppression of eating. Atropine methyl nitrate 
and scopolamine methyl nitrate, quaternary analogs which cross the 
blood-brain barrier only with difficulty, both failed to cause exten­
sive thirst suppression although they did significantly suppress eating 
at all dose levels. VJhitehouse, Lloyd, and Fifer (1964) found that 
both atropine sulfate and atropine methyl nitrate given to rats at a 
dose level of 2 mg/kg severely impaired food intake during a two hour 
feeding period following injection.
The suppression of food intake is felt to be a function of the 
peripheral effects of cholinergic attenuation, and not to be due to 
central activity (for a discussion of the pharmacology of atropine and 
scopolamine, see Appendix I). Several lines of evidence suggest this 
interpretation. First, the quaternary compounds are slightly more 
potent in their suppressive effects than are the centrally active ter­
tiary compounds, a result which is in accord with the peripheral activ­
ities of these compounds (Goodman & Gilman, 1965). Further, Keehn and
Nagai (1969) found that trihexyphenidyl (Artane), an anticholinergic 
which causes only mild dryness of the mouth and throat, suppressed the 
water consumption of rats under the influence of schedule-induced poly­
dipsia, but did not influence the number of food reinforcements consumed 
by the subjects.
The data from studies of the effects of atropine and scopolamine on 
liquid reinforced behavior suggest that their effects are a compound 
function of the dose level, the number of drug administrations, and the 
reinforcement schedule employed, Herrnstein (1958) trained food deprived 
rats to respond on a multiple schedule containing four components: FI 5
minutes, S^, Sidrnan avoidance, and another SA. Reinforcement was 0,3 cc 
sweetened condensed milk, and scopolamine was given at dose levels of 
.05, .1, .2, .4, ,8, and 1.6 rag/kg. The FI component showed a decreased
J
response rate with doses at or greater than ,1 mg/kg. The FI quarter- 
life (the amount of time it takes for the subject to emit ̂  of the total 
interreinforcement responses— -a measure of FI scalloping) was found to 
be inversely related to dose magnitude. The and avoidance response 
rates showed an inverted U-shaped relation to dose magnitude. Finally, 
one subject showed progressively decreasing effects following repeated 
administrations of .1 mg/kg scopolamine. While •'food” was used as the 
reinforcer, interpretation of the decreased response rate on the FI com­
ponent must await further information on the effect of cholinergic atten­
uation on the consumption of non-water liquids. While in this case the 
peripheral effects of scopolamine cannot explain the decrease in "food" 
reinforced responding, the liquid nature of the reinforcer might relate 
to the suppression of the thirst circuit.
Innis and Staddon (1969) also found a loss of timing behavior in 
FI responding for a reinforcement of water with sweetened condensed 
milk, as well as an apparent decrease in response rate, when scopol­
amine (.5 mg/kg) was given. Methyl scopolamine produced neither the 
loss of timing behavior nor the decrease in response rate. The finding 
that central cholinergic attenuation results in a loss of timing be­
havior is consistent with the results of other work using FI and DRL 
schedules of reinforcement (Carlton, 1963; Boren & Navarro, 1959; Willis 
& Windland, 1968).
Boren and Navarro (1959) trained rats on a multiple FR FI schedule 
with water reinforcement. The subjects were then given either atropine 
(.1, 1.0, 2.0, or h.O rag/kg) or scopolamine (.1, .2, .h, .8, 1.6, or 
3.2 mg/kg). At high doses, the temporal patterning of both the FR and 
the FI components of the multiple schedule was disrupted and changed to 
steady responding. The average FR rate decreased at these doses, though 
the FI rate did not. The FI showed a decreased terminal rate and the 
post-reinforcement pause was eliminated. At medium doses the FI changed
a ■"
temporal pattern, but the FR did not— an indication that the schedules 
were differentially sensitive to atropine and scopolamine. At low 
doses which did not alter temporal patterning, there was some evidence 
of stimulation in that the average FI and FR rates were increased.
Hanson, Witoslawski, and Campbell (I967), using monkeys trained on a 
multiple VI (Con FR FR-shock) schedule, found that scopolamine (.039- 
.625 mg/kg) decreased VI responding for sweetened condensed milk, had 
minimal effect on the concurrent.schedule component, and increased
8
responding. The decrease in VI responding was minimal at the lowest 
dose used, with response rate an inverse function of the dose magnitude. 
Willis and Windland (1968) gave repeated injections of 20 mg/kg atropine 
to rats trained to respond for water on either a multiple FR DRL schedule 
or a multiple VI FI schedule. Again, VI responding was decreased, and 
repeated administration of the agent had no effect on the response sup­
pression. All injections of atropine also decreased response rates on 
the FR schedule. Response rates were increased on the DRL schedule and 
decreased on the FI schedule. In some of the subjects these effects 
diminished on subsequent injections of atropine, suggesting that the 
effect of attenuation of central cholinergic activity on those schedule 
components (DRL and FI) involving timing behavior decreases with repeated 
administration of the anticholinergic agent.
Table 1 summarizes the data from these studies concerning the effects 
of dose level and repeated administration of atropine and scopolamine on 
liquid-reinforced responding in six operant schedules. It is readily 
apparent that dose level and the number of drug administrations are strong 
factors in the effect of cholinergic attenuation on operant responding.
Purpose of the Present Research
Dry food has not been used as a reinforcer in the investigation of the 
effects of cholinergic attenuation on operant responding. The present 
study was designed to compare the effect of a relatively low dose (2 rag/kg) 
of atropine on VI responding for either food or water reinforcement.
A VI schedule was selected because it offered the advantage of response 
stability and a minimum of confounding temporal factors. This allowed
Table i, General effects of atropine and scopolamine on response 
rate in six liquid-reinforced operant schedules. (+ indicates rate 
increase, 0 indicates no change, and - indicates rate decrease.)
Schedule
Low
Dose
Medium High RepeatedAdministration
VI
FI
O(-)
0(+)
FR
Sidman
Avoidance
S*
Ho change, or 
effect may 
diminish
-, change in -, change in Effect may
temporal pattern temporal pattern diminish
O(-)
Effect may 
diminish
Effect may 
increase or 
diminish
DRL Effect may 
diminish
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easy assessment of the differential interaction of food or water rein­
forcement with cholinergic attenuation. While a ratio schedule might 
have been chosen, it was felt that the more intermediate rates usually 
obtained from short-interval VI responding would be more amenable to 
response rate manipulation.
Both atropine sulfate and atropine methyl nitrate were expected to 
suppress responding for the dry food pellets, since the peripheral con­
sequences (especially the dry mouth and throat) of cholinergic attenua­
tion were expected to add an aversive component to the reinforcing 
stimulus. That the suppression is due to the peripheral rather than the 
central actions of the drugs was expected to show up in several ways.
First, both atropine sulfate and atropine methyl nitrate should sup­
press responding. Second, atropine methyl nitrate, which has somewhat 
greater peripheral activity than the tertiary salt, should suppress 
responding to a greater extent than does atropine sulfate, Finally, since 
the central ‘'hunger drive" mechanisms would not be affected by cholin­
ergic attenuation, the subjects were expected to begin responding at 
* "
or about their criterion rate. This rate was then expected to decrease 
as a function of the number of reinforcements received. Thus, a higher 
percentage of the total responses was expected to occur during the first 
half of the day‘s session, in comparison with a control group.
Water reinforced responding was expected to be minimally affected by 
this dose level of atropine. Some slight reduction in responding was 
expected to follow the administration of atropine sulfate (although the 
reduction was not expected to be statistically significant), and atropine 
methyl nitrate was expected to cause no change in the response rate.
CHAPTER II. METHOD
Subjects
Forty-two male Long-Evans hooded rats, 90-120 days of age, were 
randomly divided into six equal groups. The subjects were maintained 
at 80$ of their estimated growth curves; three groups by controlled 
feeding at the end of each day's session, and three by timed access 
to water at the end of each day's session. All subjects were housed 
in individual home cages.
The subjects were tested in Lehigh Valley two-bar rat boxes, which 
were housed in sound-insulated, ventilated chests. The left bar and 
the cue lights were removed from each box, and their openings covered 
with a metal plate set flush with the wall. Water reinforcements were 
delivered by a Lehigh Valley Model 1351 liquid dipper, and food rein­
forcements by a Scientific Prototype Model D700 pellet dispenser. Each 
bar required a minimum force of 12 gm in order to activate the electronic 
programming equipment, which was housed in a separate room.
Procedure
All subjects were trained to bar-press on an arithmetic VI 30 
second (5-55 second range) schedule for either food (9^ mg Noyes pellet) 
or water (,04cc, 4 second presentation) reinforcement. Each subject 
was tested for one 16 minute period (32 reinforcements) per day, to a 
criterion of either five consecutive days where the response total 
fell within + 10$ of the mean response total for the previous five
12
days, or 60 days, whichever came first. For 10 days following cri­
terion, the subjects received i.p. injections of either 1 ml/kg iso­
tonic saline (Groups F/S and W/S; that is, food or water reinforcement 
with saline injection), 2 mg/kg atropine sulfate in isotonic saline 
(Groups F/AS and W/AS), or 2 mg/kg atropine methyl nitrate in iso­
tonic saline (Groups F/AMN and W/AMN).
The injections, which were made using a blind procedure (the 
experimenter did not know which agent he was injecting into any given 
subject), were administered 30 minutes prior to the day's session.
Data were collected on the total number of responses per session, 
as well as on the number of responses in the first and second half of 
each session.
13
CHAPTER III. RESULTS
Eight subjects were tested for the full 60 days without reaching 
the percentage criterion. Since these were evenly distributed among 
the six groups (four groups had one such subject each, and two groups 
had two), no special consideration was given to the type of stability 
criterion reached.
The data from the first of the 10 drug days were discarded to 
avoid confounding by reactions to the injection procedure itself. The 
remaining nine days were grouped into blocks of three, and a suppression 
ratio (total responses in each three-day block divided by the total re­
sponses for the last three criterion days) was computed for each 
subject (Appendix III). A 2 X 3 X 3 (reinforcement by drug by trial 
block, with repeated measures on the trial block factor) factorial anal­
ysis of variance was then computed (Table 2). The reinforcement and 
drug factors were significant (p<.01), as were the drug by reinforce­
ment and drug by reinforcement by trial block interactions (p<.01),
and the reinforcement by trial block interactions (p <.05). However,
* ' 
since the three-way interaction is so complex, and accounts for so
small a/proportion of the total variance (w2 = .001), no attempt will
be made to deal with it here.
The mean suppression ratio for each group is shown in Fig. 1. As 
predicted, Groups F/AS and F/AMN both show extensive response suppression 
(Kruskal-Wallis H = 3^.60, df = 2, p<.00l), while Groups W/AS and W/AMN 
did not differ significantly from Group W/S (H = 2.39, df = 2, p>.10). 
The difference in suppression between Groups F/AS and F/AMN, while in
14
Table 2. Summary of analysis of variance.
Source SS df MS F
Between S 19.308 41
A (Reinforcement) 11.387 1 11.387 123.77**
B (Drug) 2.181 2 1.091 11.86**
AB 2.417 2 1.209 13.14**
^within groups 3.323 36 .092
Within S .195 84
C (Trials) .011 2 .006 3.00
AC .017 2 .009 *4.50
BC .014 4 .004 2.00
ABC .034 4 .009 4.50*
0 by groups .119 72 .002
* p < .05
* p < .01
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Fig. 1. Mean suppression ratio as a function of drug group.
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the predicted direction, was not statistically significant (H = .339* 
df = 1, p>.50).
The mean suppression ratios for the reinforcement by trial block 
interactions are shown in Fig, 2. While the interaction was, as stated 
above, significant at p<.01, neither trend was individually significant 
(H = 1.6*+, df = 2, p >. 10 for food reinforced subjects and H = 2.39, 
df = 2, p>.!0 for the water reinforced subjects).
Finally, the proportion of responses made in the first half of each 
drug session was computed for each food reinforced subject (Appendix III), 
and the mean proportion for each food group over the last five drug days 
was determined (Fig. 3). While the results for Group F/AMN were in the 
predicted direction, the effect was not significant (H = 1.87, df = 2, 
p>.25).
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CHAPTER IV. DISCUSSION
Food Reinforcement
The present results support the previous research showing that both 
atropine sulfate and atropine methyl nitrate suppress eating behavior.
The earlier suggestion (Stein, 1963) that this suppression is due to the 
peripheral action of the anticholinergic agents receives at best only 
minimal support here. While both agents did suppress food-reinforced 
behavior (and atropine methyl nitrate has only minimal central activity—  
if any— at this dose level), Group F/AMN did not have a significantly 
greater degree of response suppression than did Group F/AS. Further, 
while Group F/AMN did tend to give a greater proportion of its total 
responses in the first half of the trial interval than did Group F/S, 
Group F/AS gave the least proportion of first-half responses of the three 
groups. Again, however, these differences were not statistically 
significant. Thus, neither hypothesis (that Group F/AMN would show 
more suppression of food-reinforced responding than would Group F/AS,
and that both Groups F/AMN and F/AS would give a greater proportion of*
first-half responses than would Group F/S) was supported by the present 
data. A discussion of the possible implications of the first-half 
response data from Group F/AS is given in Appendix IV.
One line of evidence does suggest that the suppressed food rein­
forced responding is due to the decreased incentive value of the food 
pellets. Such an explanation is compatible with the tendency for the 
subjects in both Group F/AS and Group F/AMN to leave more than 50$ of 
the reinforcement pellets they received uneaten (Table 3). Faidherbe,
20
Table 3. Proportion of nonconsumad reinforcement pellets.
Group Subject
Mean
Reinforcements
Received
Mean
Proportion
Uneaten
Minimum
Proportion
Uneaten
Maximum
Proportion
Uneaten
3 4.6 .402 .000 1.000
7 19.5 .078 .000 .167F/AMN 1? 22,0 .082 .000 .273
22 19.9 .073 .000 .250
25 13.6 .257 .000 .625
5 12.0 .283 .000 .66?F/AS 8 24.8 .042 .000 .125
16 23.6 .215 .000 .613
24 16.4 .206 .000 .643
2 30.7 .003 .000 .032
6 25.7 .011 .000 .038
F/S 12 31.1 .000 .000 .000
19 31.5 .000 .000 .000
21 31.4 .000 .000 .000
Note: This data had not begun to be collected until several
of the subjects in each group had already been tested. Nevertheless, 
a statistical analysis was performed, and was significant. (H = 8.865, 
p < .01; From Diamond, S. Information and error; An Introduction to 
statistical analysis. New York: Basic Books, Inc., 1959, p. 282.)
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/Richelle, and Schlag (1962) have explained reinforcement nonconsumption 
during methylphenidate action as being due to response perseveration 
resulting from the generalized activation generated by this compound.
This explanation might hold for the nonconsumption of reinforcement by 
Group F/AS as well, since atropine sulfate and scopolamine do lead to 
response perseveration (Hearst, 1959; Carlton, 1961). However, response 
perseveration will not serve as an explanation for the nonconsumption 
of reinforcement t»y Group F/AMN. Another explanation, that the periph­
eral action of both atropine sulfate and atropine methyl nitrate made 
eating of the dry food pellets aversive, might better be able to deal 
with the present results. In this case, a large number of secondary 
reinforcers, including the sound of the pellet dispenser and the sight 
of the pellets, as well as the general environmental stimuli, would serve 
to maintain responding— although at a lower rate.
Water Reinforcement
Suppression of water responding was not found for either Group W/AS 
or Group W/AMN, a result which is in accord with previous work (Stein, 
1963)» and is consistent with the suggestion that the effects of cholin­
ergic attenuation on thirst-related behavior is dependent upon the 
amount of the anticholinergic agent given.
It is quite likely that the degree of suppression is not a simple 
function of the degree of central cholinergic attenuation. If this 
were the case, there would have been some suppression for Group W/AS, 
since it has been demonstrated that atropine sulfate is active centrally
at the dose level used— both in terms of behavioral measures in rats 
and monkeys (Samuel, Kodama, & Mennear, 1965; Whitehouse, 1964, 1967; 
Whitehouse, Lloyd, & Fifer, 1964) and as measured by EEG changes in 
cats (Torii & Wikler, 1966). The amount of response suppression is 
more likely to be a complex function of the central attenuation in re­
lation to the amount of anticholinergically-induced peripheral feedback. 
This feedback would serve to activate central mechanisms which through 
their activity allow the central thirst system to operate even though 
one or more of its components are partially blocked. Since atropine 
works by competitive antagonism (Goodman and Gilman, 1965), the degree 
of attenuation can be overcome by increasing the amount of acetylcholine 
available at the receptor membrane. Increased peripheral feedback can, 
by increased stimulation of the presynaptic membrane, cause the release 
of an increased amount of acetylcholine at the synapse, thereby allowing 
the system to operate in the presence of a relatively small amount of 
atropine. As the dose level increases, the degree of central attenuation 
(or the amount of atropine available at the synapse) should become great 
enough that the increased peripheral feedback Would have minimal effect, 
and thirst-related behavior would show maximal suppression.
Proposed Research
Several lines of research are suggested by the present study. First, 
of course, would be an investigation of the role played by peripheral 
feedback in the central suppression of thirst-related behavior. This 
question can be approached in at least two ways. The amount of peripheral
23
feedback occuring prior to the administration of the anticholinergic 
agent can be varied by the manipulation of the deprivation state. For 
a given dose magnitude, it would be expected that the degree of sup­
pression would be inversely related to the degree of deprivation.
Further, this relationship would diminish as the dose magnitude increases, 
until at some relatively high dose magnitude suppression would be at its 
maximum, with the degree of deprivation having little effect on the 
degree of suppression. Another approach would be to vary the amount of 
drug-induced peripheral feedback for a given deprivation state. For 
instance, dose equivalence on several independent measures of central 
activity might be determined for atropine sulfate and trihexyphenidyl.
It is then possible that a dose level of trihexyphenidyl might then be 
expected to cause greater suppression of thirst-related behavior than 
the centrally equivalent dose of atropine sulfate, because of the lesser 
degree of salivary inhibition caused by the former agent.
Another line of research might involve the study of the role of the 
peripheral consequences of a pharmacological agent on the nonconsumption 
of reinforcement. The suggestion is that the agent might act periph­
erally to increase or decrease the palatability (textural, gustatory, 
or even olfactory) of the reinforcer, and thereby affect responding for 
that reinforcer in a way ■unrelated to the central activity of that agent. 
It would be, therefore, appropriate for the experimenter, before applying 
a behavioral test of central activity, to determine if the agent acts 
to change the reinforcing properties of the reinforcer selected. This 
can be tested in a number of ways, including ad lib consumption compared
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with non-drug baselines, changes in selection preferences (although 
here the effect on the alternative selection must be considered), and 
changes in response rate for the reinforcer on the task which has been 
shown to be unaffected by the central action of the agent to be employed.
A final avenue of research, related to the question of incentive 
value changes, is the question of the type of incentive offered by 
sweetened condensed milk— regardless of the type of deprivation 
schedule employed. The data from the Hanson, Witoslawski, and Campbell 
(1967) study showing a VI response decrease on the administration of 
scopolamine when this liquid is used as reinforcement for food-deprived 
monkeys, suggests that in spite of the "food" characteristics of the 
reinforcsr and the food deprivation, inhibition of the thirst system 
by cholinergic attenuation may have served to suppress responding for it 
in the same way that such attenuation suppresses water reinforced respond­
ing. If this is the case, then textural (and other peripheral) qualities 
of the reinforcsr must be considered as well as those qualities it holds 
in relation to the deprivation conditions employed whenever a behavioral
* -r*'
test- of drug action is to be employed.
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CHAPTER V. SUMMARY
Forty-two male Long-Evans hooded rats were trained to bar-press on 
a VI 30 second schedule for either water (three groups of seven rats) or 
food (three groups of seven rats) reinforcement. Following the attain­
ment of a stability criterion, all subjects received i.p. injections of 
either 2 mg/kg atropine sulfate, 2 mg/kg atropine methyl nitrate, or 2 
ml/kg isotonic saline. Each subject received a total of 10 injections, 
which were given using a blind procedure.
A 2 X 3 X 3 (reinforcement by drug by trial block, with repeated 
measures on the trial blocks factor) analysis of variance was computed 
using the mean suppression ratio determined for each group. The rein­
forcement and drug factors, and the drug by reinforcement and the drug 
by reinforcement by trial blocks interactions, were all significant at 
p<,01. The reinforcement by trial blocks interaction was significant 
at p <.05.
Further analysis of the data showed that both atropine sulfate and 
atropine methyl nitrate suppressed VI responding for food reinforcement.
.a “
Some support for the suggestion that this suppression was due to the 
peripheral actions of the drugs was obtained from the nonconsumption of 
a large proportion of the reinforcement pellets t>y the test subjects.
Neither agent had a significant effect on water-reinforced responding. 
It was suggested that suppression of thirst-related behavior by anti­
cholinergic substances is a dose-related function of both the central and 
the peripheral consequences of cholinergic attenuation.
In the light of the present results, several further avenues of
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research were recommended. First, the role of peripheral feedback in the 
central suppression of thirst-related behavior could be investigated by 
manipulating either the deprivation state or the amount of drug-induced 
peripheral feedback. Second, the role of the peripheral consequences of 
drug administration on reinforcement nonconsumption might be investigated 
across a wide spectrum of reinforcements and of pharmacological agents. 
Finally, it was suggested that central cholinergic attenuation may suppress 
responding for sweetened condensed milk, in spite of its use as a "food'1 
reinforcer, because of its liquid nature.
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APPENDIX I. THE PHARMACOLOGY OF ATROPINE AND SCOPOLAMINE
Chemistry, Mechanism, and Specificity of Action
Atropine and scopolamine inhibit the action of acetylcholine on 
structures innervated by postganglionic cholinergic nerves and on smooth 
muscles that respond to acetylcholine but lack cholinergic innervation. 
They are, therefore, known as antimuscarinic agents, Antimuscarinic 
agents have considerably less effect on the action of acetylcholine at 
other sites, although high doses of atropine can block transmission at 
autonomic ganglia and at skeletal neuromuscular junctions. These agents 
are also active in the central nervous system.
Figure 4 shows the structural formulas of atropine and scopolamine, 
which are esters formed by the combination of an aromatic acid (tropic 
acid) and an organic base, either tropine or scopine, Scopine differs 
from tropine only in having an oxygen bridge between carbon atoms 6 and 
7 of the base. This oxygen bridge is the sole difference between atropine 
and scopolamine.
Atropine and scopolamine act through a competitive antagonism to 
acetylcholine and other muscarinic agents (Goodman & Gilman, 1965). This 
antagonism is surmountable by increasing the concentration of acetyl­
choline at the receptor sites of the effector organ. As stated above, 
these agents act at the cholinergic receptor sites of those peripheral 
structures either stimulated or inhibited by muscarine (including 
exocrine glands, smooth muscle, and cardiac muscle), as well as in the 
central nervous system.
Atropine is highly selective as an antagonist of muscarinic agents—
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so much so that atropine blockade of the action of other types of drugs 
has been taken as evidence that they act through cholinergic mechanisms 
(Goodman & Gilman, 1965). This specificity of action is lost, however, 
at high doses, where atropine may inhibit responses to histamine, 5-HT, 
and norepinephrine. Also, atropine-induced parasympathetic block may be 
preceded by a brief phase of mild stimulation. This is especially noticed 
in the heart, where a brief bradycardia (probably due to central action) 
may precede the peripherally-induced tachycardia. Furthermore, it has 
been suggested (Averill & Lamb, 1959; Ashford, Penn, & Ross, 1962) that 
low concentrations of atropine may also directly stimulate isolated tissue.
Pharmacological Actions (Central)
In the central nervous system, atropine stimulates the medulla and 
higher cerebral centers. At clinical doses (.5-1.0 mg in humans), this 
effect is usually confined to a mild vagal stimulation. At toxic doses 
of atropine central excitation becomes more prominent, with symptoms of 
restlessness, irritability, disorientation, hallucinations, or delirium. 
With still higher doses, stimulation is followed by depression and med­
ullary paralysis, resulting in death. Scopolamine, at therapeutic doses, 
produces drowsiness, euphoria, fatigue, and dreamless sleep. Both agents 
have been used in the treatment of parkinsonism, and scopolamine has been 
found to have ten times the potency of atropine in the alleviation of 
postural tremor in monkeys with subthalamic or midbrain reticular lesions 
(Vernier & Unna, 1956).
In general, atropine acts to decrease EEG activity in man and lower
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animals. Drowsiness and flattening of EEG with disappearance of alpha 
activity has been found in humans at doses of atropine from 1.95 to 
9.75 ®g (White, Rinaldi, & Himwich, 1956). Dogs given atropine show 
high voltage slow waves and spindle burst EEG activity regardless of 
whether the animals were lying quietly with their eyes closed or were 
moving about (Wikler, 1952)» This phenomenon, known as dissociation, 
has also been observed in cats and rabbits (Bradley & Elkes, 1953* 1957* 
Bach, Kelly, & Staub, 1955* Longo, 1956; Chow, Dement, & Mitchell, 1959). 
Atropine has also been shown to decrease electroeortical "arousal" re­
sponses elicited by either sensory stimulation or by stimulation of the 
midbrain reticular formation (Rinaldi & Himwich, 1955* Bradley & Key, 
1958* Paul, Riehl, & Unna, 1959) without affecting the behavioral 
response to such stimulation. Ostfeld, Machne, and Unne (i960) found 
that atropine (4.5 and 6.75 mg) caused a pulse rate increase of 60$, 
saliva volume decrease of 68$, and duration Of EEG arousal response to 
both single and repetitive light flashes decrease of 50$. A decrease 
in spontaneous speech movement, decrease in memory and attention, andft
increased drowsiness were also found. The spontaneous EEG showed a 
consistent shift toward lower amplitude and slow activity, with the 
alpha index decreased by 60 percent. They concluded that the decreased 
EEG arousal response could be attributed to the action of atropine on 
the ARAS, which occurred simultaneously with and independently of the 
effects which modify the spontaneous EEG rhythm.
Antagonism by atropine of many of the central effects of acetyl­
choline, eserine, and diisopropyl fluorophosphate is a part of the
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indirect evidence that acetylcholine may act as a chemical mediator 
in the brain. While it is not known whether the observed effects 
on the central nervous system are due to direct actions on neurons 
or to antagonism of a central synaptic transmitter, the fact that 
scopolamine and atropine induced suppression of the cat reticular 
activating system can be blocked by a cholinesterase inhibitor, 
eserine, (Exley, Fleming, and Espelien, 1958) further supports the 
latter interpretation.
Pharmacological Actions (Peripheral)
In the eye, atropine and scopolamine block the responses of the 
ciliary muscle of the lens and the sphincter muscle of the iris to 
cholinergic stimulation. The pupils are dilated (mydriasis) and 
there is paralysis of accomodation (cycloplegia). The ocular effects 
develop more slowly after subcutaneous injection, and last longer than 
do the effects on salivary secretion and respiration. It has been 
suggested (Herxheimer, 1958) that a reservoir, perhaps the aqueous 
humor, accumulates the agent and later releases it to the iris and 
ciliary muscles. While atropine and scopolamine have little effect on 
intraocular pressure, they do elevate intraocular pressure when it is 
initially above normal (as in glaucoma).
Atropine and scopolamine are often used in preanesthetic medication 
because of their action on the respiratory tract. There, they inhibit 
secretions of the nose, mouth, pharynx, and bronchi (and thus dry the 
mucous membranes of .the tract), and relax the smooth muscles of the
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bronchi and bronchioles. Atropine is more potent than scopolamine in 
this latter action (Goodman & Gilman, 1965).
The main effect of atropine on the heart is to alter the rate.
With average clinical doses the rate may be temporarily decreased. This 
decrease is never great, and there are no changes in blood pressure or 
cardiac output. Larger doses cause progressively increasing tachycardia, 
although the maximal heart rate is not affected. The main change produced 
by 1.2 mg of atropine in the human ECG is in a significant lowering of 
the T waves (Nickerson & Smith, 19^9).
In the gastrointestinal tract, atropine and scopolamine can com­
pletely abolish the profuse, watery parasympathetically-induced salivary 
secretion. The mouth becomes dry, and swallowing becomes difficult 
(Ambach, 1955? Bachrach, 1958)* Relatively large doses can reduce gas­
tric secretion both in volume and total acid content, an effect that is 
especially noticable in dogs. Therapeutic doses of atropine produce 
prolonged inhibition of the motor activity of the stomach, small intestine,
and colon. This inhibition is characterized by a decrease in tone and a
* -— "
decrease in the amplitude and frequency of peristaltic contractions 
(Goodman & Gilman, 1965).
In man, atropine (1.2 mg) has many effects on the urinary tract.
It dilates the pelvis, calyx, ureters, and bladder, and increases the 
visibility of the kidneys. Atropine also shows incomplete blockade of 
the motor response of the bladder to injected choline esters or to 
parasympathetic nerve stimulation.
Small doses of atropine or scopolamine inhibit sweat gland activity
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in humans, causing the skin to become hot and dry. At higher doses, 
this inhibition may be great enough to cause a significant rise in 
body temperature. While it is possible that this rise in body tem­
perature may be due to a central action on temperature regulators, 
animals which do not sweat, such as dogs, do not show a rise in body 
temperature following atropine administration (Goodman & Gilman, 1965). 
This suggests that the temperature change is indeed a result of the 
sweating inhibition.
Tolerance, Absorption, Fate, and Excretion
Tolerance to atropine and scopolamine occurs in man to some extent. 
This is especially noticed in patients with parkinsonism, who may take 
daily doses of atropine or scopolamine that, if given in a first admin­
istration, would result in poisoning. While habituation and addiction 
do not occur, vomiting, sweating, and salivation have been found in 
parkinsonism patients when their large therapeutic doses are suddenly 
withdrawn (Goodman & Gilman, 1965).
Atropine and scopolamine are rapidly absorbed from the gastrointes­
tinal tract, and are also absorbed from the other mucosal surfaces of 
the body. Atropine is rapidly taken up from the blood and is distrib­
uted throughout the body. Much of the agent is destroyed in the liver 
by enzymatic hydrolysis, and some is excreted unchanged in the urine. 
However, the amount so excreted in man is unclear, ranging from 1 3$ 
after lh hours (Tonneson, 1950)♦ to 50$ after 2h hours (Gosselin, 
Gabourel, & Wills, i960). This excretion of unchanged atropine and
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scopolamine makes recognition of their presence in the system possible 
by a simple, rapid, and presumptive test, A drop of urine in the eye of 
a cat will cause dilation of the pupil if it contains even a small 
amount of atropine or scopolamine (Goodman & Gilman, 1965),
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APPENDIX II. THE ROLE OF THE CEREBRAL VENTRICLES 
IN THE CHEMICAL MEDIATION OF THIRST
It has recently been suggested that at least a part of the effect 
on drinking by carbachol may be mediated through the cerebral ventri­
cles— either by general modification of the milieu of the ventricles 
or by stimilation of certain (unspecified) receptors that may line 
the walls of the ventricles. Routtenberg (196?) cites several argue- 
ments in favor of this hypothesis. First, the data indicates that 
structures showing carbachol-induced drinking lie close to the midline, 
with increasing lateral distance correlated with decreased effective­
ness. Second, carbachol applied to the fornix causes drinking. This 
would be difficult to interpret if the carbachol is thought to act at 
synaptic sites. Third, chemical stimulation of the septum elicits 
drinking, an effect which is also brought about by septal lesions.
The proximity of the third and lateral ventricles to the limbic 
system, which is so widely represented in the thirst system, is cited 
as indirect evidence in support of the ventricular modification hypoth­
esis. Finally, the hypothalamic areas indicated by Grossman (i960) 
that induce drinking following carbachol application lie close to the 
ventricles and are typically medial and dorsal to those hypothalamic 
areas found by Anand (1961) to cause adipsia when lesioned. Routtenberg 
feels that this indicates that the results might better be explained by 
diffusion of the test agents into the cerebral ventricles, where they 
exert their effect.
Support for this hypothesis has been minimal, however. Levitt (196?)
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cites four additional lines of evidence in favor of Routtenberg*s 
hypothesis. First, drinking has not as yet been successfully 
triggered in rats by electrical stimulation of most of the limbic 
sites'where a cholinergic stimulus has been successful. Second, the 
minimal drinking latency after localized brain injections is about 
three seconds (and is often longer), a result that is easily explained 
if diffusion to a distant site is postulated. Third, unless diffusion 
to a distant site is postulated, it is hard to explain the fact that 
atropine blocks cholinergically-induced thirst when applied to a posi­
tive contralateral site. Finally, Fisher and Levitt (unpublished) 
have found that carbachol can induce drinking when placed in the 
ventricles, and ventricular atropine can successfully block cholinergic 
induction of drinking at other sites. Thus cholinergic agents and 
their inhibitors can act either within the ventricles or by diffusion 
from the ventricular spaces to influence tissue involved in the media­
tion of drinking behavior. However, data from sites close to but not
within the posterior horn of the lateral ventricle, as well as from
*
injection into negative hippocampal areas, have failed to show drinking 
following normal or reduced cholinergic stimulation. Furthermore, it 
would be difficult for ventricular mediation to serve as the explaination 
for the drinking following cholinergic stimulation of the cingulate 
cortex. The thickest portion of the corpus callosum overlays access to 
ventricular spaces in this region, and Feldberg (1963) has reported that 
diffusion through white matter is often slow or negligible.
Meyers and Cicero (1968) failed to obtain significant changes in
3?
water intake in excess of baseline levels by intraventricular micro- 
injections of five dose levels of carbachol. Khavari, Hesbink, and 
Traupman (1968) replicated this result, and further found that eserine, 
an anticholinesterase found by Miller (1965) to increase drinking when 
injected into the preoptic region of slightly water deprived rats, failed 
to induce drinking when given intraventricularly. Indeed, the highest 
dose used (4.0/4g) brought about a decrease in drinking— an effect which 
may be related to drug toxicity at that dose level.
Finally, Mountford (1969) found that direct application of carbachol 
to the rat hippocampus resulted in greater increases in drinking than 
did similar applications to the adjacent lateral ventricles. This result 
is in contradiction to the hypothesis that drinking modifications are the 
result of diffusion by the test chemicals to active sites in or near the 
cerebral ventricles.
Thus, the question of the role played by the cerebral ventricles in 
this circuit is as yet unresolved, although the weight of the evidence
lies strongly in favor of a structural circuit rather than action by
* —  -
diffusion into the ventricles.
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APPENDIX III. RAW DATA 
Total Responses: Criterion and Drug Blocks
Group Sub.iect Criterion Block 1 Block 2 Block 3
2 404? 1481 738 845
6 1365 253 215 223
10 1709 1206 1205 1463
F/S 12 5838 4098 4769 4892
15 1947 2004 2269 1776
19 2992 2326 2607 1752
21 3879 3679 3200 2696
3 3765 21 7 37
7 3892 56 263 127
11 2692 234 208 27
F/AMN 14 1559 137 9 121
17 3209 192 383 320
22 2654 95 97 197
25 1532.... 111 299 83
5 1133 48 60 388 870 206 284 81
9 931 25 7 3
F/AS 16 5022 1092 867 391
18 873 60 113 27420 3394 27 111 7024 4416 . ... 865 61 409
29 2419 2198 1909 1884
38 1070 927 838 89842 549 420 430 494
W/S 43 1044 688 605 835
45 ^ 1803 1927 I892 197647 i 1979 1751 2130 1868
27 605 537 . 486 __ 50828 1675 1596 1665 1638
35 964 872 1216 804
37 2449 2798 2001 2004
W/AMN 40 2013 1814 1978 201744 2092 2023 2309 2033
51 3478 2132 2209 248148 2318 1319 958 158930 1313 975 1231 125534 646 521 470 401
39 952 884 1049 968
W/AS 41 1037 827 884 92346 592 686 694 6 56
50 1328 1010 1308 1308
26 1376 823- 1046 .....m
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Suppression Ratios: Sub.jects by Trial Bloeks
Group Subject Trial Block 1 Trial Block 2 Trial Block 3
2 .366 .182 .209
6 .185 .158 .163
10 .706 .705 .856
F/S 12 .702 .817 .838
15 1.029 I.I65 .912
19 .777 .871 .586
21 .948 .825 .695
3 .006 .002 .010
7 .014 .068 .033
11 .087 .077 .010
f/amn 14 .088 .006 .078
17 .060 .119 .100
22 .036 .037 .074
25 .072 .195... .054
5 .042 .053 .0348 .237 .326 .093
9 .027 .008 .003
F/AS 16 .217 .173 .078
18 .069 .129 .314
20 .008 .033 .02124 .196 .014 .093
29 .909 .789 .779
38 .866 .783 .839
42 .765 .783 .900
W/S 43 .659 .580 .800
45 1.069 1.049 1.096
47 .885 1.076 .944
27 .888 .803 .840
28 > .953 .994 .978
35 .905 1.261 .834
37 1.143 ..817 .818
W/AMN 40 .901 .983 1.002
44 .967 1.104 .972
51 .613 .635 .71348 .569.. .... .413 _ _ .686
30 .743 .938 .95^
34 .807 .728 .621
39 .929 1.102 1.017
W/AS 41 .797 .852 .890
46 1.159 1.172 1.108
50 .761 .985 .985
26 .598 .760 .694
Proportion of Responses in First Half of Drug Session: 
Food Reinforced Subjects
Group Sub.iect Percent
2 .561
6 .648
10 .509
F/S 12 •453
15 .382
19 .438
21 .447
3 .881
7 .467
11 .355F/AMN 14 .266
17 .892
22 .744
25 .500
5 .3198 .520
9 .125
F/AS 16 .698
18 .49320 .69324 _,163
ki
APPENDIX IV. ATROPINE SULFATE AND FIRST-HALF RESPONDING
While the results concerning first-half responding were not statis­
tically significant, the data for Group F/AS merit some discussion in 
the light of recent data on the effect of cholinergic attenuation on 
habituation. Carlton (1963, 1968) and Carlton and Vogel (1965, 1967) 
have demonstrated that central cholinergic attenuation results in the 
suppression of habituation, a conclusion which has been supported by 
Leaton (1968) using an exploratory incentive as the reinforcement for 
position discrimination in a T-maze. Subjects given scopolamine prior 
to training trials learned to enter the exploratory-reinforced (by junk 
objects) arm 100$ of the time, and learned to reverse this preference 
when the reinforced arm was reversed. Saline controls consistently 
chose the exploratory arm about 60$ of the time, a choice preference 
that was maintained upon reversal. The lower preference for the explor­
atory aim on the part of the controls might be explained as being due 
to a decreased incentive value resulting from habituation in that arm.
The present^ experiment may also offer some opportunity for this 
suppression of habituation to take place. If warm-up decrement (the 
decreased response rate often seen at the beginning of a free operant 
session) can be thought of as a brief period of habituation during which 
exploratory responses compete in strength with the desired operant 
response— and observation of the subjects suggests that this is the case—  
then atropine sulfate should extend this period of decreased lever 
responding, and Group F/AS would be expected to give a proportionately 
fewer number of lever responses during the first half of the session 
than either of the other groups.
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